Home » Topics » Regulatory » Patents

Patents
RSS

Janssen Pharmaceutica describes HCV NS5B inhibitors

March 22, 2019

XW Laboratories identifies ROS production inhibitors

March 22, 2019

Netherlands Translational Research Center divulges IDO1 inhibitors

March 22, 2019

Chronos Therapeutics presents orexin receptor antagonists

March 22, 2019

e-Therapeutics patents new hedgehog signaling inhibitors

March 22, 2019

Vivace Therapeutics presents YAP1/TEAD interaction inhibitors

March 21, 2019

Protein disulfide-isomerase inhibitors discovered at MUSC Foundation for Research Development

March 21, 2019

Merck & Co. identifies adenosine A2A and/or A2B receptor antagonists

March 21, 2019

Chinese Academy of Sciences patents collagen-targeting VEGF

March 21, 2019

Hangzhou Pulve Biotechnology describes chimeric antigen receptors targeting mesothelin

March 21, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...